Your browser doesn't support javascript.
loading
Brolucizumab for pre-treated patients with choroidal neovascularization and signs of tachyphylaxis to aflibercept and bevacizumab.
Boltz, Agnes; Radunsky, Katharina; Weingessel, Birgit; Vécsei-Marlovits, Veronika Pia.
Affiliation
  • Boltz A; Department of Ophthalmology, Hietzing Hospital, Wolkersbergenstraße 1, 1130, Vienna, Austria. agnes.boltz@gesundheitsverbund.at.
  • Radunsky K; Karl-Landsteiner Institute for Process Optimization and Quality Management in Cataract Surgery, Vienna, Austria. agnes.boltz@gesundheitsverbund.at.
  • Weingessel B; Department of Ophthalmology, Hietzing Hospital, Wolkersbergenstraße 1, 1130, Vienna, Austria.
  • Vécsei-Marlovits VP; Karl-Landsteiner Institute for Process Optimization and Quality Management in Cataract Surgery, Vienna, Austria.
Graefes Arch Clin Exp Ophthalmol ; 260(8): 2561-2566, 2022 Aug.
Article in En | MEDLINE | ID: mdl-35348844
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Choroidal Neovascularization Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Graefes Arch Clin Exp Ophthalmol Year: 2022 Document type: Article Affiliation country: Austria
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Choroidal Neovascularization Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Graefes Arch Clin Exp Ophthalmol Year: 2022 Document type: Article Affiliation country: Austria